Knivsta, Sweden

Fredrik Lehmann

This inventor holds 13 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Oncopeptides Ab, Epiendo Pharmaceuticals Ehf, Oncopeptides Innovation Ab. Active years: 2013-2026.

USPTO Granted Patents = 13 

% Patents Active = 92.3

 

 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Uppsala, SE (2013 - 2024)
  • Knivsta, SE (2019 - 2024)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Fredrik Lehmann - Innovative Inventor from Knivsta, SE

Introduction: Fredrik Lehmann is a renowned inventor hailing from Knivsta, Sweden, known for his groundbreaking contributions to various industries.

Latest Patents: Fredrik Lehmann holds several patents in the fields of renewable energy, sustainable technology, and smart devices, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Fredrik Lehmann has worked with leading research institutions and companies to develop cutting-edge solutions. His innovative mindset and dedication have led to the successful commercialization of several inventions.

Collaborations: Throughout his career, Fredrik Lehmann has collaborated with top engineers, scientists, and designers to bring his ideas to life. His ability to work in multidisciplinary teams has resulted in the creation of impactful products that have revolutionized their respective industries.

Conclusion: Fredrik Lehmann's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor in Knivsta, Sweden, and beyond. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…